P365: Sleep-disordered breathing in neonatal PURA syndrome
Abstract
Supplemental oxygen was continued throughout hospitalization. Based on initial sleep study findings, tracheostomy was recommended but ultimately deferred in favor of conservative management. Pharmacological interventions included caffeine (20 mg/kg daily, starting DOL 31) to reduce apnea frequency and oral albuterol (0.1 mg TID, starting DOL 59) to target the neuromuscular junction component of weakness.
Fields of Study & Subjects
Neuroscience of respiration and sleep
Obstructive Sleep Apnea Research
Genomics and Rare Diseases
Publication details
- Journal / source
- Genetics in Medicine Open
- Volume
- 4
- Pages
- 103859–103859
- Publication date
- 1 January 2026
- Language
- EN